Oracle Alpha Inc. Repare Therapeutics Inc. Transaction History
Oracle Alpha Inc.
- $55.7 Billion
- Q1 2024
A detailed history of Oracle Alpha Inc. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Oracle Alpha Inc. holds 19,482 shares of RPTX stock, worth $67,602. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,482
Previous 12,288
58.54%
Holding current value
$67,602
Previous $89.7 Million
2.29%
% of portfolio
0.16%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.8MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$35.9 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$11.7 Million4.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$11.5 Million0.26% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$10.3 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$9.18 Million19.39% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $146M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...